30
Participants
Start Date
April 30, 2009
Primary Completion Date
January 31, 2013
Study Completion Date
December 31, 2013
Erlotinib
Erlotinib will be administered at 150 mg once daily by mouth on the following schedule: days 2-5, 9-12,16-26.
gemcitabine
The dose for gemcitabine is 1,000 mg/m2 administered over 30 minutes as an intravenous infusion. The doses are administered weekly for 3 weeks (Days 1, 8 and 15) followed by one week of rest during which gemcitabine is not given. This 4 week period (28 days) constitutes a cycle.
University of California Davis Cancer Center, Sacramento
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles
Collaborators (1)
National Cancer Institute (NCI)
NIH
Genentech, Inc.
INDUSTRY
University of California, Davis
OTHER